If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClarkson Regulatory News (CKN)

Share Price Information for Clarkson (CKN)

Share Price is delayed by 15 minutes
Get Live Data
4,474.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 16.00 (0.361%)
Market Cap: £1.37b
CKN Live PriceLast checked at - London Stock Exchange

Intraday Clarkson Share Chart

Director/PDMR Shareholding

6 Nov 2009 15:10

RNS Number : 1420C
Clarkson PLC
06 November 2009
Β 

ο»Ώ

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

This form is intended for use by anΒ issuerΒ to make aΒ RISΒ notification required byΒ DRΒ 3.1.4R(1).

Β 

(1)

AnΒ issuerΒ making a notification in respect of a transaction relating to theΒ sharesΒ or debentures of theΒ issuerΒ should completeΒ boxes 1 to 16, 23 and 24.

(2)

AnΒ issuerΒ making a notification in respect of a derivative relatingΒ toΒ theΒ sharesΒ of theΒ issuerΒ should completeΒ boxes 1 to 4, 6, 8,Β 13, 14, 16, 23 and 24.Β 

(3)

AnΒ issuerΒ making a notification in respect of options granted to aΒ director/person discharging managerial responsibilitiesΒ should completeΒ boxes 1 to 3Β and 17 to 24.Β 

(4)

AnΒ issuerΒ making a notification in respect of aΒ financial instrumentΒ relating to theΒ sharesΒ of theΒ issuerΒ (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.Β 

Β 

Please complete all relevant boxes in block capital letters.

1.Β Name of theΒ issuer

CLARKSONΒ PLC

………………………………

2.Β State whether the notification relates to (i) a transaction notified in accordance withΒ DTRΒ 3.1.2Β R;Β 

(ii) a disclosure made in accordance with LR 9.8.6R(1) or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006).

NOTIFICATION MADE IN RESPECT OF (i)

………………………………

3.Β Name ofΒ person discharging managerial responsibilities/director

PAUL WOGAN

………………………………

4.Β State whether notification relates to aΒ personΒ connected with aΒ person discharging managerial responsibilities/directorΒ named in 3 and identify theΒ connected person

N/A

………………………………

5.Β Indicate whether the notification is in respect of a holding of theΒ personΒ referred to in 3 or 4 above or in respect of a non-beneficial interest

AS PER 3 ABOVE

………………………………

6.Β Description ofΒ sharesΒ (includingΒ class), debentures or derivatives or financial instruments relating toΒ shares

ORDINARY SHARES OF 25P EACH

………………………………

7.Β Name of registered shareholders(s) and, if more than one, the number ofΒ sharesΒ held by each of them

PAUL WOGAN

………………………………

8Β State the nature of the transaction

PURCHASE

………………………………

9.Β Number ofΒ shares, debentures or financial instruments relating toΒ sharesΒ acquired

5,000

………………………………

10.Β Percentage of issuedΒ classΒ acquired (treasury sharesΒ of thatΒ classΒ should not be taken into account when calculating percentage)

0.026%

………………………………

11.Β Number ofΒ shares, debentures or financial instruments relating toΒ sharesΒ disposed

N/A

………………………………

12.Β Percentage of issuedΒ classΒ disposed (treasury sharesΒ of thatΒ classΒ should not be taken into account when calculating percentage)Β 

N/A

………………………………

13.Β Price perΒ shareΒ or value of transaction

Β£8.00

………………………………

14.Β Date and place of transaction

ENGLANDΒ Β - 6Β NOVEMBERΒ 2009

………………………………

15.Β Total holding following notification and total percentage holding following notification (anyΒ treasury sharesΒ should not be taken into account when calculating percentage)

10,000Β Β SHARESΒ 

0.052%

………………………………

16.Β Date issuer informed of transaction

6Β NOVEMBERΒ 2009

………………………………

If aΒ person discharging managerial responsibilitiesΒ has been granted options by theΒ issuerΒ complete the following boxes

17Β Date of grant

N/A

………………………………

18.Β Period during which or date on which it can be exercised

N/A

………………………………

19.Β Total amount paid (if any) for grant of the option

N/A

………………………………

20.Β Description ofΒ sharesΒ or debentures involved (classΒ and number)

N/A

………………………………

21.Β Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

N/A

………………………………

22.Β Total number ofΒ sharesΒ or debentures over which options held following notification

N/A

………………………………

23.Β Any additional information

N/A

………………………………

24.Β Name of contact and telephone number for queries

JEFF WOYDAΒ 

020 7334 0000

………………………………

NameΒ and signatureΒ ofΒ dulyΒ authorisedΒ officerΒ ofΒ issuerΒ responsible for making notification

STEPHEN DEASEYΒ -Β COMPANY SECRETARY

………………………………

Date of notification

6 November 2009

ENDΒ 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSUUGBUGUPBGAQ
Date   Source Headline
31st Jan 20255:00 pmRNSHolding(s) in Company
13th Jan 20254:30 pmRNSHolding(s) in Company
10th Jan 20257:00 amRNSTrading Statement
2nd Jan 20252:15 pmRNSTotal Voting Rights
2nd Dec 202412:30 pmRNSTotal Voting Rights
4th Nov 20242:30 pmRNSDirector/PDMR Shareholding
1st Nov 202412:00 pmRNSTotal Voting Rights
29th Oct 20249:00 amRNSAdditional Listing
28th Oct 202412:00 pmRNSBlock listing Interim Review
9th Oct 20244:30 pmRNSHolding(s) in Company
1st Oct 202411:08 amRNSTotal Voting Rights
30th Sep 202411:35 amRNSDirector/PDMR Shareholding
2nd Sep 202410:39 amRNSTotal Voting Rights
12th Aug 20244:30 pmRNSDirector/PDMR Shareholding
5th Aug 20247:01 amRNSAppointment of Non-Executive Director
5th Aug 20247:00 amRNSInterim results
1st Aug 20241:00 pmRNSDirector Declaration
1st Aug 202410:00 amRNSTotal Voting Rights
1st Jul 20244:00 pmRNSTotal Voting Rights
3rd Jun 202411:15 amRNSTotal Voting Rights
9th May 20245:01 pmRNSDirector/PDMR Shareholding
9th May 20245:00 pmRNSResult of AGM
9th May 202412:00 pmRNSAGM Trading Statement
1st May 20242:45 pmRNSTotal Voting Rights
1st May 20242:42 pmRNSBlock listing Interim Review
26th Apr 20245:15 pmRNSHolding(s) in Company
22nd Apr 20245:00 pmRNSDirector/PDMR Shareholding
17th Apr 20243:30 pmRNSDirector/PDMR Shareholding
3rd Apr 20244:45 pmRNSAnnual Financial Report
2nd Apr 20241:48 pmRNSTotal Voting Rights
19th Mar 20243:30 pmRNSHolding(s) in Company
4th Mar 20247:01 amRNSDirectorate Change
4th Mar 20247:00 amRNSPreliminary results
1st Feb 20242:11 pmRNSTotal Voting Rights
5th Jan 20247:00 amRNSTrading Statement
2nd Jan 20242:30 pmRNSTotal Voting Rights
1st Dec 202311:45 amRNSTotal Voting Rights
15th Nov 20238:00 amRNSDirector Declaration
1st Nov 202311:30 amRNSTotal Voting Rights
26th Oct 202311:00 amRNSBlock listing Interim Review
23rd Oct 20239:00 amRNSAdditional Listing
12th Oct 20233:45 pmRNSHolding(s) in Company
13th Sep 20233:30 pmRNSHolding(s) in Company
7th Aug 20237:00 amRNSInterim results
24th Jul 20234:00 pmRNSHolding(s) in Company
3rd Jul 202312:00 pmRNSTotal Voting Rights
1st Jun 202312:30 pmRNSTotal Voting Rights
11th May 20234:15 pmRNSResult of AGM
11th May 202312:00 pmRNSAGM Trading Statement
2nd May 202312:15 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.